Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis.

ABSTRACT:

Background

People accessing and completing treatment for tuberculosis can face large economic costs, even when treatment is provided free of charge. The WHO End TB Strategy targets the elimination of catastrophic costs among tuberculosis-affected households. While low-income and middle-income countries (LMICs) represent 99% of global tuberculosis cases, only 29 of 135 LMICs had conducted national surveys of costs for patients with tuberculosis by December, 2022. We estimated costs for patients with tuberculosis in countries that have not conducted a national survey, to provide evidence on the economic burden of tuberculosis in these settings and inform estimates of global economic burden.

Methods

We extracted data from 22 national surveys of costs faced by patients with tube

SUBMITTER: Portnoy A 

PROVIDER: S-EPMC10522775 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature